770718-79-1 Usage
Derivative of 1H-indole
It is a modified version of the parent compound 1H-indole, with additional functional groups attached to its structure.
2,3-difluoro-6-nitrophenoxy group
A specific functional group attached to the seventh carbon atom of the indole ring, which consists of two fluorine atoms and a nitro group on the 6th carbon of a phenoxy ring.
Attachment to the seventh carbon atom
The 2,3-difluoro-6-nitrophenoxy group is connected to the indole ring through the seventh carbon atom, influencing its chemical properties and reactivity.
Potential applications in organic synthesis
The unique structure of 1H-Indole, 7-(2,3-difluoro-6-nitrophenoxy)makes it a valuable compound for the development of new synthetic methods and reactions in organic chemistry.
Potential applications in pharmaceutical research
The compound's structure and properties may be useful in the development of new drugs and therapeutic agents, making it an important target for pharmaceutical research.
Safety precautions
Due to the presence of potentially reactive functional groups, it is essential to handle 1H-Indole, 7-(2,3-difluoro-6-nitrophenoxy)with care and follow proper safety protocols in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 770718-79-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,0,7,1 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 770718-79:
(8*7)+(7*7)+(6*0)+(5*7)+(4*1)+(3*8)+(2*7)+(1*9)=191
191 % 10 = 1
So 770718-79-1 is a valid CAS Registry Number.
770718-79-1Relevant academic research and scientific papers
Process for preparing pyridazinone compounds
-
Page/Page column 12, (2008/06/13)
The present invention provides a process for the preparation 6-[3-(hetero)aryloxy-2-fluoro-benzyl]-2H-pyridazin-3-one compounds 1 where R2 is an optionally substituted aryl or an optionally substituted heteroaryl, R6 is NO2, NH2, alkyl, halogen, or a function group readily derived therefrom and R4c is hydrogen or alkyl. There also is provided a process for the preparation of phenylacetic acid compounds 2, wherein R2 and R6 are as defined previously and R5a is hydrogen or alkyl, which are useful for the preparation of pyridazinone compounds.
Non-nucleoside reverse transcriptase inhibitors
-
Page/Page column 78, (2010/02/08)
This invention relates to novel pyridazinone derivatives of formula I wherein R1-R4, R7, R8 and X1 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated
